Cart
sales@molnova.com
Benzcyclane
CAS No. 2179-37-5
Benzcyclane( —— )
Catalog No. M32802 CAS No. 2179-37-5
Benzcyclane (Benzcyclan) is an inhibitor of platelet aggregation and also a vasodilator that can be used in a variety of peripheral circulation disorders.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 149 | Get Quote |
|
| 5MG | 187 | Get Quote |
|
| 10MG | 323 | Get Quote |
|
| 25MG | 503 | Get Quote |
|
| 50MG | 679 | Get Quote |
|
| 100MG | 888 | Get Quote |
|
| 500MG | 1773 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBenzcyclane
-
NoteResearch use only, not for human use.
-
Brief DescriptionBenzcyclane (Benzcyclan) is an inhibitor of platelet aggregation and also a vasodilator that can be used in a variety of peripheral circulation disorders.
-
DescriptionBenzcyclane (Bencyclane; Benzcyclan) is a platelet aggregation inhibitor and a vasodilator effective in a variety of peripheral circulation disorders.
-
In Vitro——
-
In VivoBenzcyclane, although capable of aggregating platelets by itself at very high concentrations, shows a striking inhibitory effect, over a wide range of concentrations, both on platelet aggregation induced by ADP, epinephrine or collagen and on platelet adhesiveness to glass or collagen. Clot retraction is also clearly inhibited. Benzcyclane induces use-dependent inhibition of Na channels in muscle, similarly as do class 1 antiarrhytnmic drugs. Inhibition was observed with both normal and cevadine-modified Na channels.
-
Synonyms——
-
PathwayOthers
-
TargetPlatelet aggregation
-
RecptorPlatelet aggregation
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2179-37-5
-
Formula Weight289.46
-
Molecular FormulaC19H31NO
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(C1(OCCCN(C)C)CCCCCC1)C2=CC=CC=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ponari O, et al. In vitro effects of bencyclan on coagulation, fibrinolysis and platelet function. Arzneimittelforschung. 1976;26(8):1532-8.?
molnova catalog
related products
-
SDZ-62-434
SDZ-62-434, a platelet-activating factor inhibitor with antitumor activity, inhibits bombesin- and platelet-derived growth factor-induced DNA synthesis in quiescent Swiss 3T3 cells, making it a potential candidate for studying leukemia, human xenograft colorectal cancer, and lung cancer.
-
Pseudojervine
Pseudojervine is derived from Veratrum nigrum L. Pseudojervine exhibits feeble inhibition activity against platelet aggregation.
-
Mutant EGFR inhibito...
Mutant EGFR inhibitor is a selective and potent Mutated EGFR inhibitor, inhibits L858R activating mutant, the Exonl9 deletion activating mutant and the T790M resistance mutant.
